Bemcentinib
id:
bemcentinib-271-4215455
title:
Bemcentinib
text:
Bemcentinib, also known as BGB324 or R428, is an experimental oral small molecule that is an inhibitor of AXL kinase. Bemcentinib was licensed from Rigel Pharmaceuticals by BerGenBio and currently undergoing six Phase II trials in various solid and hematological tumors as monotherapy and in combination with immunotherapy, chemotherapy, and targeted therapeutics.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Bemcentinib
date created:
date modified:
2023-08-13T08:26:34Z
main entity:
{"identifier":"Q27236818","url":"https://www.wikidata.org/entity/Q27236818"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c4/Bemcentinib.svg","width":968,"height":468}
fields total:
13
integrity:
15